| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_665813d23f67e65fedd7f7f24b7f7c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49c8084f87387a1ae8561d9319801a34 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D10B2501-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D06M15-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B21-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B21-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A41D1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A41D3-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate |
2004-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfef4b3943f7c5a28b57e3379036f0da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f508ba6a56e77d09eb10398cefedad7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6990152baef76880d616b75f035eb49c |
| publicationDate |
2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050081597-A |
| titleOfInvention |
Drug for osteoporosis having inhibition effect on cancer comprising ginkgo biloba extracts as the active ingredient |
| abstract |
The present invention relates to a therapeutic agent for osteoporosis containing ginkgo biloba extract as an active ingredient, and since the ginkgo biloba extract contains a large amount of phytoestrogen such as quercetin and kaempferol, the ginkgo biloba extract according to the present invention Is a selective estrogen receptor modulator, which may be useful for treating osteoporosis without breast cancer side effects. |
| priorityDate |
2004-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |